Pacira BioSciences, Inc. (PCRX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US6951271005
Pacira BioSciences, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 726.41 m USD |
| Gross profit | 576.66 m USD |
| Operating income | 19.19 m USD |
| EBIT | 11.59 m USD |
| Net income | 7.03 m USD |
| Diluted EPS – continuing operations | 0.16 USD |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Pacira BioSciences, Inc.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.
More stocks
- Esentia Energy Development SA (ESENTIAII.MX)
- SonoScape Medical Corp (300633.SZ)
- Lightspeed Commerce Inc (LSPD.TO)
- Guangdong Marubi Biotechnology Co (603983.SS)
- Vanchip (Tianjin) Technology Co. Ltd. A (688153.SS)
- Mezzion Pharma Co.Ltd (140410.KQ)
- Hongrun Construction Group Co Ltd (002062.SZ)
- PHIBRO ANIMAL HEALTH CORP (PAHC)
- Mayr-Melnhof Karton AG (MMK.VI)
- Huadian Ener-B (900937.SS)
- Pagaya Technologies Ltd. (PGY)
- Suzhou Betely Polymer Materials Co., Ltd. (301697.SZ)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.